Almoosa 2025 net profit soars to SAR 236.5M; Q4 at SAR 82M

Almoosa Health Co. reported a net profit surge to SAR 236.5 million for 2025, from SAR 49.4 million in the year-earlier period.

This was primarily driven by higher revenue from increased patient volumes and admissions, as well as a more favorable case mix with a higher proportion of complex and specialized procedures. The increase was also supported by the expansion of clinical services through the addition of new clinics across various specialties, which enhanced service capacity and contributed to higher patient activity.

Profitability was further supported by improved operational efficiency and stronger cost management across the group’s hospitals and medical centers. In addition, the group recorded lower finance costs following the settlement of certain financing facilities earlier in the year after the IPO, which positively impacted the bottom line.

The company’s operating profit for 2025 increased to SAR 225.7 million, following the classification of the loss on investment as a non-operating item.

Net profit for the period was also affected by non-cash items arising from the mark-to-market valuation of derivative instruments and treatment of fair value loss on investments.

Q4 2025 net earnings surged to SAR 82 million, compared to SAR 9.01 million in Q4 2024.

On a sequential basis, net profit jumped 58.7% from SAR 51.64 million in Q3 2025.

Total shareholders’ equity rose to SAR 1.92 billion by Dec. 31, 2025, compared to SAR 626.3 million in the prior-year period.

Attached Documents

View More Financial Results